4506.T
Sumitomo Dainippon Pharma Co Ltd
Price:  
815 
JPY
Volume:  
18,890,000
Japan | Pharmaceuticals

4506.T WACC - Weighted Average Cost of Capital

The WACC of Sumitomo Dainippon Pharma Co Ltd (4506.T) is 5.0%.

The Cost of Equity of Sumitomo Dainippon Pharma Co Ltd (4506.T) is 6.3%.
The Cost of Debt of Sumitomo Dainippon Pharma Co Ltd (4506.T) is 5.5%.

RangeSelected
Cost of equity5.2% - 7.4%6.3%
Tax rate27.7% - 30.6%29.15%
Cost of debt4.0% - 7.0%5.5%
WACC4.0% - 6.1%5.0%
WACC

4506.T WACC calculation

CategoryLowHigh
Long-term bond rate1.4%1.9%
Equity market risk premium6.1%7.1%
Adjusted beta0.620.71
Additional risk adjustments0.0%0.5%
Cost of equity5.2%7.4%
Tax rate27.7%30.6%
Debt/Equity ratio
1.121.12
Cost of debt4.0%7.0%
After-tax WACC4.0%6.1%
Selected WACC5.0%

4506.T's CAPM model and how its cost of Equity is calculated

The Cost of Equity reflects the return a company needs to deliver to shareholders to justify the risk of investing in its shares. It’s computed using the Capital Asset Pricing Model (CAPM), which blends the risk-free rate, the stock’s beta, and the market risk premium.

This method evaluates the stock’s risk compared to a safe investment and the market’s overall volatility.

Here’s how we figure out the cost of equity for 4506.T:

cost_of_equity (6.30%) = risk_free_rate (1.65%) + equity_risk_premium (6.60%) * adjusted_beta (0.62) + risk_adjustments (0.25%)

We include the risk adjustments, which range from 0% to 1%, to keep our WACC conservatives, especially for companies traded in developing markets.